<\/b><\/p>\n
<\/b><\/p>\n
MONDAY, July 6, 2020 (HealthDay News) — Only a minority of American women have heard of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) and understand its association with breast implants, according to a study published in the July issue of Plastic and Reconstructive Surgery<\/i>.<\/p>\n
Erica Lee, from the Johns Hopkins University School of Medicine in Baltimore, and colleagues surveyed 500 American women to assess baseline knowledge and concern regarding BIA-ALCL.<\/p>\n
The researchers found that 12 percent of respondents had received breast implants and 73 percent knew someone with implants. Of all respondents, 13.6 percent had previously heard of BIA-ALCL; 51.7 percent of respondents with implants had previously heard of BIA-ALCL. Even after receiving information about BIA-ALCL risk, 58.4 percent of respondents were still willing to receive a reconstructive implant and 45.8 percent were willing to receive a cosmetic implant, while 35.8 percent reported they would be less likely to receive an implant. Two-thirds (66.7 percent) of the respondents with breast implants reported some degree of concern regarding BIA-ALCL, while just over one-third (35.0 percent) were strongly considering removing their implants.<\/p>\n
“Our findings can help surgeons navigate the risks of BIA-ALCL with current and prospective patients and can guide future public education efforts on BIA-ALCL,” the authors write.<\/p>\n
One author disclosed financial ties to Allergan, LifeSprout, and Vioptix.<\/p>\n